Table 2.
Means, Standard Deviations, and Effect-sizes for Outcome Measures for CBT+DCS and CBT+Placebo Treatment Groups
| D-Cycloserine Group (N=15) |
Placebo Group (N=15) |
Effect Sizes | |||
|---|---|---|---|---|---|
| Measure | Mean | SD | Mean | SD | Cohen’s dΩ |
| CY-BOCS Total Severity | |||||
| Pretreatment | 24.1 | 4.4 | 26.0 | 3.8 | 0.46 |
| Mid-treatment | 15.6 | 6.8 | 17.9 | 4.5 | 0.40 |
| Post-treatment | 6.8 | 6.0 | 11.0 | 6.6 | 0.67 |
| CGI-Severity | |||||
| Pretreatment | 4.6 | 0.83 | 5.1 | 0.74 | 0.63 |
| Mid-treatment | 3.5 | 0.92 | 3.9 | 0.59 | 0.52 |
| Post-treatment | 2.0 | 1.0 | 3.0 | 1.2 | 0.91 |
| ADIS-CSR | |||||
| Pretreatment | 5.1 | 0.79 | 5.3 | 0.70 | 0.27 |
| Post-treatment | 1.5 | 1.5 | 2.5 | 1.8 | 0.61 |
| MASC | |||||
| Pretreatment | 41.7 | 15.4 | 39.9 | 13.7 | 0.12 |
| Post-treatment | 31.4 | 19.7 | 34.6 | 14.7 | 0.19 |
| CDI-Short Form | |||||
| Pretreatment | 2.6 | 3.3 | 3.4 | 2.8 | 0.27 |
| Post-treatment | 1.4 | 2.5 | 2.2 | 2.1 | 0.36 |
SD=Standard Deviation
Ω
Between-group Effect Size at each time point using the pooled standard deviation